Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in more than 30 countries throughout the world.
Location: United States, North Carolina, Durham
Employees: 1001-5000
Total raised: $165M
Founded date: 2021
Investors 1
| Date | Name | Website |
| 31.10.2023 | Harbert Gr... | harbert.ne... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.01.2025 | - | $165M | - |
Mentions in press and media 3
| Date | Title | Description |
| 17.01.2025 | The Week’s Biggest Funding Rounds: Biotech And Space Tech Bring In The Money | 9 Shares Email Facebook Twitter LinkedIn Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a w... |
| 14.01.2025 | Caidya Receives $165M Growth Investment From Rubicon Founders | Caidya, a Raleigh, NC-based global mid-sized CRO, received a $165M growth investment from Rubicon Founders. The company intends to use the funds to support its next phase of growth, enabling continued organic expansion along with exploratio... |
| - | Caidya | “Caidya formerly dMed Clinipace are a leading clinical research organization with a personal approach.” |